Overall CNS gets a fundamental rating of 5 out of 10. We evaluated CNS against 238 industry peers in the Capital Markets industry. While CNS has a great profitability rating, there are some minor concerns on its financial health. CNS is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year CNS was profitable.
In the past year CNS has reported a negative cash flow from operations.
Of the past 5 years CNS 4 years were profitable.
CNS had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

CNS's Return On Assets of 20.48% is amongst the best of the industry. CNS outperforms 97.48% of its industry peers.
CNS has a Return On Equity of 29.83%. This is amongst the best in the industry. CNS outperforms 95.38% of its industry peers.
CNS has a Return On Invested Capital of 24.24%. This is amongst the best in the industry. CNS outperforms 97.90% of its industry peers.
CNS had an Average Return On Invested Capital over the past 3 years of 28.30%. This is significantly above the industry average of 7.27%.
The last Return On Invested Capital (24.24%) for CNS is well below the 3 year average (28.30%), which needs to be investigated, but indicates that CNS had better years and this may not be a problem.

		Industry Rank	Sector Rank
ROA	20.48%
ROE	29.83%
ROIC	24.24%

ROA(3y)20.51%

ROA(5y)25.29%

ROE(3y)38.03%

ROE(5y)48.18%

ROIC(3y)28.3%

ROIC(5y)38.19%

1.3 Margins

Looking at the Profit Margin, with a value of 29.73%, CNS is in the better half of the industry, outperforming 73.53% of the companies in the same industry.
CNS's Profit Margin has declined in the last couple of years.
CNS's Operating Margin of 33.83% is fine compared to the rest of the industry. CNS outperforms 65.13% of its industry peers.
In the last couple of years the Operating Margin of CNS has declined.
The Gross Margin of CNS (88.60%) is better than 92.86% of its industry peers.
In the last couple of years the Gross Margin of CNS has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	33.83%
PM (TTM)	29.73%
GM	88.6%

OM growth 3Y-9.18%

OM growth 5Y-3.03%

PM growth 3Y-6.88%

PM growth 5Y-2.25%

GM growth 3Y0.74%

GM growth 5Y0.55%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CNS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CNS has an Altman-Z score of 9.58. This indicates that CNS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.58, CNS belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
CNS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	9.58

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.79 indicates that CNS may have some problems paying its short term obligations.
The Current ratio of CNS (0.79) is worse than 63.45% of its industry peers.
A Quick Ratio of 0.79 indicates that CNS may have some problems paying its short term obligations.
The Quick ratio of CNS (0.79) is worse than 63.03% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.79
Quick Ratio	0.79

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.80% over the past year.
Measured over the past 5 years, CNS shows a small growth in Earnings Per Share. The EPS has been growing by 3.74% on average per year.

EPS 1Y (TTM)5.8%

EPS 3Y-5.81%

EPS 5Y3.74%

EPS Q2Q%3.85%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%17.21%

3.2 Future

CNS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.66% yearly.
The Revenue is expected to grow by 6.66% on average over the next years.

EPS Next Y8.49%

EPS Next 2Y8.3%

EPS Next 3Y8.22%

EPS Next 5Y8.66%

Revenue Next Year9.4%

Revenue Next 2Y7.67%

Revenue Next 3Y7.17%

Revenue Next 5Y6.66%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.26 indicates a rather expensive valuation of CNS.
Compared to the rest of the industry, the Price/Earnings ratio of CNS indicates a slightly more expensive valuation: CNS is more expensive than 63.03% of the companies listed in the same industry.
CNS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.21.
A Price/Forward Earnings ratio of 19.60 indicates a rather expensive valuation of CNS.
CNS's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.26, CNS is valued at the same level.

		Industry Rank	Sector Rank
PE	21.26
Fwd PE	19.6

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNS indicates a somewhat cheap valuation: CNS is cheaper than 78.15% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	17.2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of CNS may justify a higher PE ratio.

PEG (NY)2.5

PEG (5Y)5.68

EPS Next 2Y8.3%

EPS Next 3Y8.22%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.58%, CNS has a reasonable but not impressive dividend return.
CNS's Dividend Yield is comparable with the industry average which is at 6.10.
CNS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.

		Industry Rank	Sector Rank
Dividend Yield	3.58%

5.2 History

The dividend of CNS decreases each year by -7.12%.
CNS has been paying a dividend for at least 10 years, so it has a reliable track record.
CNS has decreased its dividend in the last 3 years.

Dividend Growth(5Y)-7.12%

Div Incr Years2

Div Non Decr Years2

5.3 Sustainability

76.25% of the earnings are spent on dividend by CNS. This is not a sustainable payout ratio.

DP76.25%

EPS Next 2Y8.3%

EPS Next 3Y8.22%

More info and screens

Find the best dividend stocks

Show peers with best dividend

COHEN & STEERS INC / CNS FAQ

What is the ChartMill fundamental rating of COHEN & STEERS INC (CNS) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CNS.

What is the valuation status for CNS stock?

ChartMill assigns a valuation rating of 2 / 10 to COHEN & STEERS INC (CNS). This can be considered as Overvalued.

Can you provide the profitability details for COHEN & STEERS INC?

COHEN & STEERS INC (CNS) has a profitability rating of 7 / 10.

Can you provide the financial health for CNS stock?

The financial health rating of COHEN & STEERS INC (CNS) is 5 / 10.

What is the expected EPS growth for COHEN & STEERS INC (CNS) stock?

The Earnings per Share (EPS) of COHEN & STEERS INC (CNS) is expected to grow by 8.49% in the next year.